anti-CLDN6 antibody drug conjugate (Shanghai Genechem/I-Mab Biopharma)

N/A

Report date: 2025/03/14 16:51:41

Base Information

Drug Nameanti-CLDN6 antibody drug conjugate (Shanghai Genechem/I-Mab Biopharma)
Drug Alias NameGB-7008-03-vcMMAEGB-7008-01-vcMMAE
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionClaudin 6 inhibitors
TargetsClaudin 6
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Genechem Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Genechem Co LtdI-Mab Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A